Aditi Sapre

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients.

Daniel Bloomfield, J. Mckenney, R. Pasternak, 2009, American heart journal.